Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001193125-26-114552
Filing Date
2026-03-18
Accepted
2026-03-18 18:39:36
Documents
1
X0202

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D  
1 primary_doc.xml SCHEDULE 13D 11404
  Complete submission text file 0001193125-26-114552.txt   12896
Mailing Address C/O NUCANA PLC, 3 LOCHSIDE WAY EDINBURGH X0 EH12 9DT
Business Address
Griffith Hugh (Filed by) CIK: 0001296964 (see all company filings)

Type: SCHEDULE 13D

Mailing Address 3 LOCHSIDE WAY EDINBURGH X0 EH12 9DT
Business Address 3 LOCHSIDE WAY EDINBURGH X0 EH12 9DT 44-0-131-357-1111
NuCana plc (Subject) CIK: 0001709626 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: SCHEDULE 13D | Act: 34 | File No.: 005-90138 | Film No.: 26771267
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)